Near normalization of adult height and body proportions by growth hormone in pycnodysostosis

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 6, 2010, Pages 2827-2831

  Rothenbühler, Anya ^a   Piquard, Catherine ^a   Gueorguieva, Iva ^a   Lahlou, Najiba ^a   Linglart, Agnès ^a   Bougnères, Pierre ^a  

^a HÔPITAL SAINT VINCENT DE PAUL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; HUMAN GROWTH HORMONE; SOMATOMEDIN C; CATHEPSIN K; DNA; RECOMBINANT PROTEIN;

ARTICLE; CASE REPORT; CHILD; CLINICAL FEATURE; DWARFISM; FEMALE; HEIGHT; HUMAN; MALE; MISSENSE MUTATION; PRIORITY JOURNAL; PYKNODYSOSTOSIS; SHORT STATURE; ADOLESCENT; BODY HEIGHT; BONE DEVELOPMENT; DRUG EFFECT; DYSOSTOSIS; GENETICS; GROWTH; METABOLISM; PATHOLOGY; PHYSIOLOGY; PRESCHOOL CHILD; TREATMENT OUTCOME;

ADOLESCENT; BODY HEIGHT; BONE DEVELOPMENT; CATHEPSIN K; CHILD; CHILD, PRESCHOOL; DNA; DYSOSTOSES; FEMALE; GROWTH; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MUTATION, MISSENSE; RECOMBINANT PROTEINS; TREATMENT OUTCOME;

EID: 77954487800     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-2531     Document Type: Article

References (25)

1. Maroteaux P, Lamy M 1962 La pycnodysostose. Presse Med 70:999-1002
2. Andren L, Dymling JF, Hogeman KE, Wendeberg B 1962 Osteopetrosis acro-osteolytica. A syndrome of osteopetrosis, acro-osteolysis and open sutures of the skull. Acta Chir Scand 124:496-507
3. Hou WS, Brömme D, Zhao Y, Mehler E, Dushey C, Weinstein H, Miranda CS, Fraga C, Greig F, Carey J, Rimoin DL, Desnick RJ, Gelb BD 1999 Characterization of novel cathepsin K mutations in the pro and mature polypeptide regions causing pycnodysostosis. J Clin Invest 103:731-738
4. Donnarumma M, Regis S, Tappino B, Rosano C, Assereto S, Corsolini F, Di Rocco M, Filocamo M 2007 Molecular analysis and characterization of nine novel CTSK mutations in twelve patients affected by pycnodysostosis. Mutation in brief #961. Online. Hum Mutat 28:524
5. Fujita Y, Nakata K, Yasui N, Matsui Y, Kataoka E, Hiroshima K, Shiba RI, Ochi T 2000 Novel mutations of the cathepsin K gene in patients with pycnodysostosis and their characterization. J Clin Endocrinol Metab 85:425-431
6. Schilling AF, Mülhausen C, Lehmann W, Santer R, Schinke T, Rueger JM, Amling M 2007 High bone mineral density in pyknodysostotic patients with a novel mutation in the propeptide of cathepsin K. Osteoporos Int 18:659-669 (Pubitemid 46525550)
7. Tezuka K, Tezuka Y, Maejima A, Sato T, Nemoto K, Kamioka H, Hakeda Y, Kumegawa M 1994 Molecular cloning of a possible cysteine proteinase predominantly expressed in osteoclasts. J Biol Chem 269:1106-1109 (Pubitemid 24032492)
8. Hunt NP, Cunningham SJ, Adnan N, Harris M 1998 The dental, craniofacial, and biochemical features of pyknodysostosis: a report of three new cases. J Oral Maxillofac Surg 56:497-504
9. Sedano HD, Gorlin RJ, Anderson VE 1968 Pycnodysostosis. Clinical and genetic considerations. Am J Dis Child 116:70-77
10. Kawahara K, Nishikiori M, Imai K, Kishi K, Fujiki Y 1977 Radiographic observations of pyknodysostosis. Report of a case. Oral Surg Oral Med Oral Pathol 44:476-482
11. Edelson JG, Obad S, Geiger R, On A, Artul HJ 1992 Pycnodysostosis. Orthopedic aspects with a description of 14 new cases. Clin Orthop Relat Res 263-276
12. Soliman AT, Rajab A, AlSalmi I, Darwish A, Asfour M 1996 Defective growth hormone secretion in children with pycnodysostosis and improved linear growth after growth hormone treatment. Arch Dis Child 75:242-244 (Pubitemid 26313273)
13. Cohen P, Rogol AD, Deal CL, Saenger P, Reiter EO, Ross JL, Chernausek SD, Savage MO, Wit JM 2008 Consensus statement on the diagnosis and treatment of children with idiopathic short stature: a summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology Workshop. J Clin Endocrinol Metab 93:4210-4217
14. Cohen P, Rogol AD, Howard CP, Bright GM, Kappelgaard AM, Rosenfeld RG 2007 Insulin growth factor-based dosing of growth hormone therapy in children: a randomized, controlled study. J Clin Endocrinol Metab 92:2480-2486
15. Ahmed ML, Yudkin PL, Macfarlane JA, McPherson K, Dunger DB 1990 Are measurements of height made by health visitors sufficiently accurate for routine screening of growth? Arch Dis Child 65:1345-1348
16. Saftig P, Hunziker E, Wehmeyer O, Jones S, Boyde A, Rommerskirch W, Moritz JD, Schu P, von Figura K 1998 Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice. Proc Natl Acad Sci USA 95:13453-13458
17. Chen W, Yang S, Abe Y, Li M, Wang Y, Shao J, Li E, Li YP 2007 Novel pycnodysostosis mouse model uncovers cathepsin K function as a potential regulator of osteoclast apoptosis and senescence.Hum Mol Genet 16:410-423
18. Everts V, Aronson DC, Beertsen W 1985 Phagocytosis of bone collagen by osteoclasts in two cases of pycnodysostosis. Calcif Tissue Int 37:25-31 (Pubitemid 15102232)
19. Everts V, Korper W, Jansen DC, Steinfort J, Lammerse I, Heera S, Docherty AJ, Beertsen W 1999 Functional heterogeneity of osteoclasts: matrix metalloproteinases participate in osteoclastic resorption of calvarial bone but not in resorption of long bone. FASEB J 13:1219-1230 (Pubitemid 29300367)
20. Gowen M, Lazner F, Dodds R, Kapadia R, Feild J, Tavaria M, Bertoncello I, Drake F, Zavarselk S, Tellis I, Hertzog P, Debouck C, Kola I 1999 Cathepsin K knockout mice develop osteopetrosis due to a deficit in matrix degradation but not demineralization. J Bone Miner Res 14:1654-1663
21. Fratzl-Zelman N, Valenta A, Roschger P, Nader A, Gelb BD, Fratzl P, Klaushofer K 2004 Decreased bone turnover and deterioration of bone structure in two cases of pycnodysostosis. J Clin Endocrinol Metab 89:1538-1547
22. Helfrich MH 2003 Osteoclast diseases. Microsc Res Tech 61:514-532
23. Fuller K, Lawrence KM, Ross JL, Grabowska UB, Shiroo M, Samuelsson B, Chambers TJ 2008 Cathepsin K inhibitors prevent matrix-derived growth factor degradation by human osteoclasts. Bone 42:200-211 (Pubitemid 350302017)
24. Ranke MB, Guilbaud O, Lindberg A, Cole T 1993 Prediction of the growth response in children with various growth disorders treated with growth hormone: analyses of data from the Kabi Pharmacia International Growth Study. International Board of the Kabi Pharmacia International Growth Study. Acta Paediatr Suppl 82(Suppl 391):82-88; discussion 89
25. Kumar S, Dare L, Vasko-Moser JA, James IE, Blake SM, Rickard DJ, Hwang SM, Tomaszek T, Yamashita DS, Marquis RW, Oh H, Jeong JU, Veber DF, Gowen M, Lark MW, Stroup G 2007 A highly potent inhibitor of cathepsin K (relacatib) reduces biomarkers of bone resorption both in vitro and in an acute model of elevated bone turnover in vivo in monkeys. Bone 40:122-131